Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Nicolas Ruffier"'
Autor:
Damian Mielecki, Mathieu Fanuel, Nicolas Ruffier, Emilie Camberlein, Ewa Szolajska, Malgorzata Podsiadla-Bialoskorska, Cyrille Grandjean, Annie Lambert, Maruthi Prasanna, Amina Fateh
Publikováno v:
Glycoconjugate Journal
Glycoconjugate Journal, Springer Verlag, 2021, 38 (4), pp.437-446. ⟨10.1007/s10719-021-09999-3⟩
Glycoconjugate Journal, Springer Verlag, 2021, pp.early access. ⟨10.1007/s10719-021-09999-3⟩
Glycoconjugate Journal, Springer Verlag, 2021, 38 (4), pp.437-446. ⟨10.1007/s10719-021-09999-3⟩
Glycoconjugate Journal, Springer Verlag, 2021, pp.early access. ⟨10.1007/s10719-021-09999-3⟩
International audience; Virus-Like Particles (VLPs) have been used as immunogenic molecules in numerous recombinant vaccines. VLPs can also serve as vaccine platform to exogenous antigens, usually peptides incorporated within the protein sequences wh
Autor:
Nicolas Ruffier, Maruthi Prasanna, Annie Lambert, Emilie Camberlein, François Trottein, Noemi Csaba, Daphnée Soulard, Cyrille Grandjean
Publikováno v:
European Journal of Pharmaceutical Sciences
European Journal of Pharmaceutical Sciences, Elsevier, 2019, 129, pp.31-41. ⟨10.1016/j.ejps.2018.12.013⟩
European Journal of Pharmaceutical Sciences, 2019, 129, pp.31-41. ⟨10.1016/j.ejps.2018.12.013⟩
European Journal of Pharmaceutical Sciences, Elsevier, 2019, 129, pp.31-41. ⟨10.1016/j.ejps.2018.12.013⟩
European Journal of Pharmaceutical Sciences, 2019, 129, pp.31-41. ⟨10.1016/j.ejps.2018.12.013⟩
Pneumococcal infections remain a major public health concern worldwide. The currently available vaccines in the market are based on pneumococcal capsular polysaccharides but they still need to be improved to secure an optimal coverage notably in popu